Deccan Health Care Ltd.
Snapshot View

32.75 -2.25 ▼-6.4%

27 June 2022, 04:01:00 PM
Volume: 60,000

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.deccanhealthcare.co.in / www.beyoungstore.com
Market Cap 55.82 Cr.
Enterprise Value(EV) 53.63 Cr. 2021-03
Financial Indicators
Earnings per share (EPS) 0.19 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 172.81 Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 47.89 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.68 Calculated using Price: 32.75
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.70 Cr. 17,043,180 Shares
FaceValue 10
Company Profile
The Company is engaged in developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products. The Company offers more than 1500 products. These products are used for various purposes such as hair care, skin care, heart care, immunity building etc. The Company offers a long-chain omerga-3 fatty acid, joint health nutrients, diacerein, antioxidants, immune enhancing components, skin ageing products, instant energy drinks, and calcium supplements; and a formula for males. The Company supplies their products in various forms such as tablets, capsules, gel, liquids, ointments, powder, pastes, etc.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-6.43%
1 Week
+1.08%
1 Month
-6.29%
3 Month
-5.62%
6 Month
+18.87%
1 Year
+7.03%
2 Year
-13.82%
5 Year
10 Year
1 years 2021-03
Return on Equity (%) 0.51
Return on Capital Employed (%) 0.81
Return on Assets (%) 0.42

Balance Sheet View Details

Particulars 1 years 2021-03 Rs. Cr.
Shh. Funds 77
Non Curr. Liab. 3
Curr. Liab. 13
Minority Int.
Equity & Liab. 92
Non Curr. Assets 26
Curr. Assets 66
Misc. Exp. not W/O
Total Assets 92

Profit Loss View Details

Particulars 1 years 2021-03 Rs. Cr.
Net Sales 34
Other Income 0
Total Income 34
Total Expenditure -32
PBIDT 2
Interest 0
Depreciation -1
Taxation 0
Exceptional Items
PAT 0
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0
Adjusted EPS 0

Cash Flow View Details

Particulars 1 years 2021-03 Rs. Cr.
Cash Fr. Operatn. 0
Cash Fr. Inv. 0
Cash Fr. Finan. 0
Net Change 0
Cash & Cash Eqvt 3

Shareholding Pattern View Details

9 Qtrs 2017-03 (%) 2018-03 (%) 2019-03 (%) 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%)
Promoter 77.79 74.51 51.39 51.30 45.61 35.94 35.70 34.89 27.60
Public 22.21 25.49 48.61 48.70 54.39 64.06 64.30 65.11 72.40
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.08

Announcements View Details

Mon, 13 Jun 2022
Board Meeting Outcome for Regulation 30 - Outcome Of Board Meeting Held On 13Th June 2022
Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at their meeting held on 13th June 2022 has approved the allotment of 13 29 750 (Thirteen Lakhs Twenty Nine Thousand Seven Hundred Fifty) equity shares of Rs. 10 each of the Company at a price of Rs. 37.60/- per share (including share premium of Rs. 27.60/- per share) amounting to Rs. 4 99 98 600/- on Preferential basis to Venture Gurukool Investment Trust (category - other than promoter) for Cash consideration.The said equity shares shall be listed on Bombay Stock Exchange Limited.The shares allotted to Venture Gurukool Investment Trust shall be locked in as specified under Chapter V of the SEBI (ICDR) Regulations.
Fri, 10 Jun 2022
Board Meeting Intimation for Allotment Of Equity Shares On Preferential Basis On 13Th June 2022
Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/06/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended a meeting of the Board of Directors of the Company shall be held on Monday the 13th of June 2022 to discuss the following matters:1. Allotment of 13 29 750 equity shares of the Company on preferential basis to Venture Gurukool Investment Trust (belonging to other than promoters) for an amount aggregating up to ? 4 99 98 600/- (Rupees Four Crore Ninety Nine Lakhs Ninety eight Thousand Six Hundred only).2. Any other businesses with the permission of Chairperson.
Mon, 06 Jun 2022
Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations 2015)
Deccan Health Care Ltd has informed BSE regarding the details of Voting results of Postal Ballot under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here

Technical Scans View Details

Mon, 27 Jun 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%

FAQ's On Deccan Health Care Ltd.

Can I Buy Deccan Health Care Shares now?

What is the Share Price of Deccan Health Care?

What is the Relative Strength Index (RSI) Value of Deccan Health Care?

What is the Market Capital (MCAP) of Deccan Health Care?

What are the key metrics to analyse Deccan Health Care?

What is the Price Performance of Deccan Health Care?